{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:37:53Z","timestamp":1793263073156,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40256-023-00619-z","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T10:02:46Z","timestamp":1703844166000},"page":"19-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature"],"prefix":"10.1007","volume":"24","author":[{"given":"Seyed Ali","family":"Mousavi-Aghdas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Farashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-040X","authenticated-orcid":false,"given":"Nasim","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"issue":"4","key":"619_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14(4):238\u201350.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"619_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00395-013-0358-9","volume":"108","author":"A Nickel","year":"2013","unstructured":"Nickel A, L\u00f6ffler J, Maack C. Myocardial energetics in heart failure. Basic Res Cardiol. 2013;108(4):358.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"619_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4161\/auto.2608","volume":"2","author":"G Takemura","year":"2006","unstructured":"Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic Degeneration and Death of Cardiomyocytes in Heart Failure. Autophagy. 2006;2(3):212\u20134.","journal-title":"Autophagy"},{"issue":"4","key":"619_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DPD Re","year":"2019","unstructured":"Re DPD, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765\u2013817.","journal-title":"Physiol Rev"},{"issue":"21","key":"619_CR5","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G. Ferroptosis. Curr Biol. 2020;30(21):R1292\u20137.","journal-title":"Curr Biol"},{"issue":"1","key":"619_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","volume":"10","author":"BT Paul","year":"2017","unstructured":"Paul BT, Manz DH, Torti FM, Torti SV. Mitochondria and iron: current questions. Expert Rev Hematol. 2017;10(1):65\u201379.","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"619_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5603\/KP.a2016.0155","volume":"75","author":"M Kasztura","year":"2017","unstructured":"Kasztura M, Dzi\u0119ga\u0142a M, Kobak K, Bania J, Mazur G, Banasiak W, et al. Both iron excess and iron depletion impair viability of rat H9C2 cardiomyocytes and L6G8C5 myocytes. Kardiol Pol. 2017;75(3):267\u201375.","journal-title":"Kardiol Pol"},{"issue":"4","key":"619_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165(4):575-82.e3.","journal-title":"Am Heart J"},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","volume":"205","author":"N Ebner","year":"2016","unstructured":"Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure. Int J Cardiol. 2016;205:6\u201312.","journal-title":"Int J Cardiol"},{"issue":"10","key":"619_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","volume":"52","author":"HF Groenveld","year":"2008","unstructured":"Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818\u201327.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"619_CR11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1161\/CIRCULATIONAHA.118.038516","volume":"139","author":"G Charles-Edwards","year":"2019","unstructured":"Charles-Edwards G, Amaral N, Sleigh A, Ayis S, Catibog N, McDonagh T, et al. Effect of iron isomaltoside on skeletal muscle energetics in patients with chronic heart failure and iron deficiency. Circulation. 2019;139(21):2386\u201398.","journal-title":"Circulation"},{"issue":"3","key":"619_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jcsm.12282","volume":"9","author":"M Tkaczyszyn","year":"2018","unstructured":"Tkaczyszyn M, Drozd M, W\u0119grzynowska-Teodorczyk K, Flinta I, Kobak K, Banasiak W, et al. Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure. J Cachexia Sarcopenia Muscle. 2018;9(3):547\u201356.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"619_CR13","doi-asserted-by":"publisher","first-page":"G199","DOI":"10.1152\/ajpgi.00412.2005","volume":"290","author":"T Ganz","year":"2006","unstructured":"Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290(2):G199-203.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","volume":"173","author":"X Yang","year":"2022","unstructured":"Yang X, Kawasaki NK, Min J, Matsui T, Wang F. Ferroptosis in heart failure. J Mol Cell Cardiol. 2022;173:141\u201353.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"619_CR15","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052\u20139.","journal-title":"Theranostics."},{"key":"619_CR16","unstructured":"Anand I, Rector T, Deswal A, Iverson E, Anderson S, Mann D, et al., editors. Relationship between proinflammatory cytokines and anemia in heart failure. Eur Heart J. 2006;27:485\u2013485."},{"issue":"1","key":"619_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure. Circulation. 2018;138(1):80\u201398.","journal-title":"Circulation"},{"issue":"21","key":"619_CR18","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","volume":"26","author":"C Opasich","year":"2005","unstructured":"Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J. 2005;26(21):2232\u20137.","journal-title":"Eur Heart J"},{"issue":"4","key":"619_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2796.1989.tb01390.x","volume":"226","author":"F Fyhrquist","year":"1989","unstructured":"Fyhrquist F, Karppinen K, Honkanen T, Saijonmaa O, Rosenl\u00f6f K. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Intern Med. 1989;226(4):257\u201360.","journal-title":"J Intern Med"},{"issue":"12","key":"619_CR20","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1161\/CIRCULATIONAHA.105.549121","volume":"112","author":"P van der Meer","year":"2005","unstructured":"van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E, et al. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation. 2005;112(12):1743\u20137.","journal-title":"Circulation"},{"issue":"6","key":"619_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1527-5299.2000.80177.x","volume":"6","author":"DS Sica","year":"2000","unstructured":"Sica DS. Pharmacotherapy in congestive heart failure: ACE inhibitors and anemia in congestive heart failure. Congestive Heart Fail (Greenwich, Conn). 2000;6(6):330\u20132.","journal-title":"Congestive Heart Fail (Greenwich, Conn)."},{"issue":"13","key":"619_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","volume":"146","author":"KF Docherty","year":"2022","unstructured":"Docherty KF, Welsh P, Verma S, Boer RAD, O\u2019Meara E, Bengtsson O, et al. iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF. Circulation. 2022;146(13):980\u201394.","journal-title":"Circulation"},{"issue":"4","key":"619_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017;19(4):522\u201330.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"619_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006;121(2):144\u201358.","journal-title":"Clin Immunol"},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2018.07.020","volume":"133","author":"I Yanatori","year":"2019","unstructured":"Yanatori I, Kishi F. DMT1 and iron transport. Free Radical Biol Med. 2019;133:55\u201363.","journal-title":"Free Radical Biol Med"},{"issue":"2","key":"619_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trsl.2010.11.002","volume":"157","author":"M Otto-Duessel","year":"2011","unstructured":"Otto-Duessel M, Brewer C, Wood JC. Interdependence of cardiac iron and calcium in a murine model of iron overload. Transl Res. 2011;157(2):92\u20139.","journal-title":"Transl Res"},{"issue":"12","key":"619_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2016-06-721183","volume":"128","author":"JL Fernandes","year":"2016","unstructured":"Fernandes JL, Loggetto SR, Ver\u00edssimo MPA, Fertrin KY, Baldanzi GR, Fioravante LAB, et al. A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major. Blood. 2016;128(12):1555\u201361.","journal-title":"Blood"},{"issue":"9","key":"619_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.bbamcr.2012.03.004","volume":"1823","author":"DM Ward","year":"2012","unstructured":"Ward DM, Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochem Biophys Acta. 2012;1823(9):1426\u201333.","journal-title":"Biochem Biophys Acta"},{"key":"619_CR29","doi-asserted-by":"crossref","unstructured":"Koz\u0142owska B, Sochanowicz B, Kraj L, Palusi\u0144ska M, Ko\u0142sut P, Szyma\u0144ski \u0141, et al. Expression of iron metabolism proteins in patients with chronic heart failure. J Clin Med. 2022;11(3).","DOI":"10.3390\/jcm11030837"},{"issue":"5","key":"619_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","volume":"58","author":"MT Maeder","year":"2011","unstructured":"Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol. 2011;58(5):474\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"619_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-017-0218-4","volume":"12","author":"ZD Zhou","year":"2017","unstructured":"Zhou ZD, Tan E-K. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol Neurodegener. 2017;12(1):75.","journal-title":"Mol Neurodegener"},{"issue":"4854","key":"619_CR32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1126\/science.2452485","volume":"240","author":"JL Casey","year":"1988","unstructured":"Casey JL, Hentze MW, Koeller DM, Caughman SW, Rouault TA, Klausner RD, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240(4854):924\u20138.","journal-title":"Science"},{"key":"619_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fphar.2014.00176","volume":"5","author":"N Wilkinson","year":"2014","unstructured":"Wilkinson N, Pantopoulos K. The IRP\/IRE system in vivo: insights from mouse models. Front Pharmacol. 2014;5:176.","journal-title":"Front Pharmacol"},{"issue":"5","key":"619_CR34","first-page":"362","volume":"38","author":"S Haddad","year":"2016","unstructured":"Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J. 2016;38(5):362\u201372.","journal-title":"Eur Heart J"},{"key":"619_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19804","volume":"5","author":"S Lakhal-Littleton","year":"2016","unstructured":"Lakhal-Littleton S, Wolna M, Chung YJ, Christian HC, Heather LC, Brescia M, et al. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. Elife. 2016;5: e19804.","journal-title":"Elife"},{"issue":"12","key":"619_CR36","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/ejhf.2731","volume":"24","author":"M Packer","year":"2022","unstructured":"Packer M. How can sodium\u2013glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron-deficient? Implications for understanding iron homeostasis in heart failure. Eur J Heart Fail. 2022;24(12):2287\u201396.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"619_CR37","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/ejhf.1781","volume":"22","author":"VG Hirsch","year":"2020","unstructured":"Hirsch VG, Tongers J, Bode J, Berliner D, Widder JD, Escher F, et al. Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction. Eur J Heart Fail. 2020;22(11):2038\u201346.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"619_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","volume":"159","author":"P Leszek","year":"2012","unstructured":"Leszek P, Sochanowicz B, Szperl M, Kolsut P, Brz\u00f3ska K, Piotrowski W, et al. Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol. 2012;159(1):47\u201352.","journal-title":"Int J Cardiol"},{"issue":"Suppl","key":"619_CR39","first-page":"2","volume":"43","author":"P Leszek","year":"2022","unstructured":"Leszek P, Lewicki S, Kozlowska B, Sochanowicz B, Kolsut P, Szymanski L, et al. The relation among myocardial iron load and the severity of heart failure. Eur Heart J. 2022;43(Suppl):2.","journal-title":"Eur Heart J"},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"8885189","DOI":"10.1155\/2020\/8885189","volume":"2020","author":"P Leszek","year":"2020","unstructured":"Leszek P, Sochanowicz B, Brz\u00f3ska K, Kraj L, Ku\u015bmierczyk M, \u015amigielski W, et al. accurate noninvasive assessment of myocardial iron load in advanced heart failure patients. Dis Markers. 2020;2020:8885189.","journal-title":"Dis Markers"},{"issue":"4","key":"619_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014254","volume":"9","author":"J N\u00fa\u00f1ez","year":"2020","unstructured":"N\u00fa\u00f1ez J, Mi\u00f1ana G, Cardells I, Palau P, Ll\u00e0cer P, F\u00e1cila L, et al. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the myocardial\u2013IRON trial. J Am Heart Assoc. 2020;9(4): e014254.","journal-title":"J Am Heart Assoc"},{"key":"619_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-physiol-020518-114742","volume":"81","author":"DM Ward","year":"2019","unstructured":"Ward DM, Cloonan SM. Mitochondrial iron in human health and disease. Annu Rev Physiol. 2019;81:453\u201382.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"619_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cmet.2015.05.013","volume":"22","author":"NS Chandel","year":"2015","unstructured":"Chandel NS. EVOLUTION of mitochondria as signaling organelles. Cell Metab. 2015;22(2):204\u20136.","journal-title":"Cell Metab"},{"issue":"2","key":"619_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158\u201367.","journal-title":"Mol Cell"},{"issue":"11","key":"619_CR45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/0022-2828(92)93098-5","volume":"24","author":"HN Sabbah","year":"1992","unstructured":"Sabbah HN, Sharov V, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol. 1992;24(11):1333\u201347.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"619_CR46","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1177\/2047487319870344","volume":"27","author":"A Aimo","year":"2020","unstructured":"Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, et al. Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020;27(5):494\u2013510.","journal-title":"Eur J Prev Cardiol"},{"issue":"14","key":"619_CR47","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.109.914911","volume":"121","author":"M Kohlhaas","year":"2010","unstructured":"Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, B\u00f6hm M, et al. Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation. 2010;121(14):1606\u201313.","journal-title":"Circulation"},{"issue":"3","key":"619_CR48","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/CIRCHEARTFAILURE.113.001062","volume":"7","author":"A Hoshino","year":"2014","unstructured":"Hoshino A, Okawa Y, Ariyoshi M, Kaimoto S, Uchihashi M, Fukai K, et al. Oxidative post-translational modifications develop LONP1 dysfunction in pressure overload heart failure. Circ Heart Fail. 2014;7(3):500\u20139.","journal-title":"Circ Heart Fail"},{"issue":"26","key":"619_CR49","doi-asserted-by":"publisher","first-page":"23357","DOI":"10.1074\/jbc.M100320200","volume":"276","author":"AC Nulton-Persson","year":"2001","unstructured":"Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem. 2001;276(26):23357\u201361.","journal-title":"J Biol Chem"},{"issue":"22","key":"619_CR50","doi-asserted-by":"publisher","first-page":"13399","DOI":"10.1074\/jbc.270.22.13399","volume":"270","author":"PR Gardner","year":"1995","unstructured":"Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells\u2217. J Biol Chem. 1995;270(22):13399\u2013405.","journal-title":"J Biol Chem"},{"key":"619_CR51","doi-asserted-by":"publisher","first-page":"102011","DOI":"10.1016\/j.redox.2021.102011","volume":"44","author":"AJM Vermorken","year":"2021","unstructured":"Vermorken AJM, Zhu J, Holvoet P, Cui Y. The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure. Redox Biol. 2021;44:102011.","journal-title":"Redox Biol"},{"issue":"7","key":"619_CR52","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","volume":"1813","author":"JS Jaswal","year":"2011","unstructured":"Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation\u2014a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta (BBA)-Mol Cell Res. 2011;1813(7):1333\u201350.","journal-title":"Biochim Biophys Acta (BBA)-Mol Cell Res"},{"issue":"11","key":"619_CR53","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1253\/circj.70.1509","volume":"70","author":"N Igarashi","year":"2006","unstructured":"Igarashi N, Nozawa T, Fujii N, Suzuki T, Matsuki A, Nakadate T, et al. Influence of \u03b2-adrenoceptor blockade on the myocardial accumulation of fatty acid tracer and its intracellular metabolism in the heart after ischemia-reperfusion injury. Circ J. 2006;70(11):1509\u201314.","journal-title":"Circ J"},{"issue":"8","key":"619_CR54","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, et al. The failing heart relies on ketone bodies as a fuel. Circulation. 2016;133(8):698\u2013705.","journal-title":"Circulation"},{"key":"619_CR55","doi-asserted-by":"crossref","unstructured":"Maejima Y. SGLT2 inhibitors play a salutary role in heart failure via modulation of the mitochondrial function. Front Cardiovasc Med. 2020;6.","DOI":"10.3389\/fcvm.2019.00186"},{"issue":"Suppl 2","key":"619_CR56","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1093\/hmg\/ddi270","volume":"14","author":"H Chen","year":"2005","unstructured":"Chen H, Chan DC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet. 2005;14(Suppl 2):R283\u20139.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"619_CR57","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1242\/jcs.114.5.867","volume":"114","author":"A Santel","year":"2001","unstructured":"Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001;114(5):867\u201374.","journal-title":"J Cell Sci"},{"key":"619_CR58","doi-asserted-by":"crossref","unstructured":"Ren L, Chen X, Chen X, Li J, Cheng B, Xia J. Mitochondrial dynamics: fission and fusion in fate determination of mesenchymal stem cells. Front Cell Dev Biol. 2020;8.","DOI":"10.3389\/fcell.2020.580070"},{"issue":"7","key":"619_CR59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/CIRCRESAHA.112.266585","volume":"111","author":"Y Chen","year":"2012","unstructured":"Chen Y, Csord\u00e1s G, Jowdy C, Schneider TG, Csord\u00e1s N, Wang W, et al. Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2+) crosstalk. Circ Res. 2012;111(7):863\u201375.","journal-title":"Circ Res"},{"issue":"5","key":"619_CR60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1091\/mbc.e12-10-0721","volume":"24","author":"OC Los\u00f3n","year":"2013","unstructured":"Los\u00f3n OC, Song Z, Chen H, Chan DC. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell. 2013;24(5):659\u201367.","journal-title":"Mol Biol Cell"},{"key":"619_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/B978-0-12-405206-2.00004-1","volume-title":"Cellular and molecular pathobiology of cardiovascular disease","author":"WE Stansfield","year":"2014","unstructured":"Stansfield WE, Ranek M, Pendse A, Schisler JC, Wang S, Pulinilkunnil T, et al. Chapter 4\u2014the pathophysiology of cardiac hypertrophy and heart failure. In: Willis MS, Homeister JW, Stone JR, editors., et al., Cellular and molecular pathobiology of cardiovascular disease. San Diego: Academic Press; 2014. p. 51\u201378."},{"issue":"8","key":"619_CR62","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/CIRCRESAHA.112.274142","volume":"111","author":"KN Papanicolaou","year":"2012","unstructured":"Papanicolaou KN, Kikuchi R, Ngoh GA, Coughlan KA, Dominguez I, Stanley WC, et al. Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res. 2012;111(8):1012\u201326.","journal-title":"Circ Res"},{"issue":"2","key":"619_CR63","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2014.12.011","volume":"21","author":"M Song","year":"2015","unstructured":"Song M, Mihara K, Chen Y, Scorrano L, Dorn GW. Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 2015;21(2):273\u201386.","journal-title":"Cell Metab"},{"key":"619_CR64","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.015","volume":"799","author":"J Khamseekaew","year":"2017","unstructured":"Khamseekaew J, Kumfu S, Wongjaikam S, Kerdphoo S, Jaiwongkam T, Srichairatanakool S, et al. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice. Eur J Pharmacol. 2017;799:118\u201327.","journal-title":"Eur J Pharmacol"},{"key":"619_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111252","volume":"188","author":"A Schiavi","year":"2020","unstructured":"Schiavi A, Strappazzon F, Ventura N. Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies. Mech Ageing Dev. 2020;188: 111252.","journal-title":"Mech Ageing Dev"},{"key":"619_CR66","doi-asserted-by":"crossref","unstructured":"Weil R, Laplantine E, Curic S, G\u00e9nin P. Role of optineurin in the mitochondrial dysfunction: potential implications in neurodegenerative diseases and cancer. Front Immunol. 2018;9.","DOI":"10.3389\/fimmu.2018.01243"},{"key":"619_CR67","doi-asserted-by":"crossref","unstructured":"Kataura T, Otten EG, Rabanal-Ruiz Y, Adriaenssens E, Urselli F, Scialo F, Fan L, Smith GR, Dawson WM, Chen X, Yue WW, Bronowska AK, Carroll B, Martens S, Lazarou M, Korolchuk VI. NDP52 acts as a redox sensor in PINK1\/Parkin-mediated mitophagy. EMBO J. 2023 Mar 1;42(5):e111372.","DOI":"10.15252\/embj.2022111372"},{"key":"619_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111245","volume":"188","author":"R Zhang","year":"2020","unstructured":"Zhang R, Krigman J, Luo H, Ozgen S, Yang M, Sun N. Mitophagy in cardiovascular homeostasis. Mech Ageing Dev. 2020;188: 111245.","journal-title":"Mech Ageing Dev"},{"issue":"7565","key":"619_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309\u201314.","journal-title":"Nature"},{"issue":"11","key":"619_CR70","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050202","volume":"21","author":"Y Hara","year":"2020","unstructured":"Hara Y, Yanatori I, Tanaka A, Kishi F, Lemasters JJ, Nishina S, et al. Iron loss triggers mitophagy through induction of mitochondrial ferritin. EMBO Rep. 2020;21(11): e50202.","journal-title":"EMBO Rep"},{"key":"619_CR71","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3389\/fmicb.2019.02478","volume":"10","author":"AD Tsaousis","year":"2019","unstructured":"Tsaousis AD. On the origin of Iron\/Sulfur cluster biosynthesis in eukaryotes. Front Microbiol. 2019;10:2478.","journal-title":"Front Microbiol"},{"issue":"1","key":"619_CR72","doi-asserted-by":"publisher","first-page":"13932","DOI":"10.1038\/ncomms13932","volume":"8","author":"S-A Freibert","year":"2017","unstructured":"Freibert S-A, Goldberg AV, Hacker C, Molik S, Dean P, Williams TA, et al. Evolutionary conservation and in vitro reconstitution of microsporidian iron\u2013sulfur cluster biosynthesis. Nat Commun. 2017;8(1):13932.","journal-title":"Nat Commun"},{"issue":"5","key":"619_CR73","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ejhf.1154","volume":"20","author":"MF Hoes","year":"2018","unstructured":"Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail. 2018;20(5):910\u20139.","journal-title":"Eur J Heart Fail"},{"key":"619_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120485","volume":"297","author":"Y Ling","year":"2022","unstructured":"Ling Y, Yang X, Zhang X, Guan F, Qi X, Dong W, et al. Myocardium-specific Isca1 knockout causes iron metabolism disorder and myocardial oncosis in rat. Life Sci. 2022;297: 120485.","journal-title":"Life Sci"},{"issue":"Pt 1","key":"619_CR75","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/bj3560061","volume":"356","author":"F Petrat","year":"2001","unstructured":"Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J. 2001;356(Pt 1):61\u20139.","journal-title":"Biochem J"},{"issue":"38","key":"619_CR76","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.0906784106","volume":"106","author":"ML-H Huang","year":"2009","unstructured":"Huang ML-H, Becker EM, Whitnall M, Rahmanto YS, Ponka P, Richardson DR. Elucidation of the mechanism of mitochondrial iron loading in Friedreich\u2019s ataxia by analysis of a mouse mutant. Proc Natl Acad Sci. 2009;106(38):16381\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"619_CR77","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1182\/blood-2008-06-161919","volume":"112","author":"O Kakhlon","year":"2008","unstructured":"Kakhlon O, Manning H, Breuer W, Melamed-Book N, Lu C, Cortopassi G, et al. Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation. Blood. 2008;112(13):5219\u201327.","journal-title":"Blood"},{"issue":"5","key":"619_CR78","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0022-2143(98)90148-2","volume":"131","author":"G Link","year":"1998","unstructured":"Link G, Saada A, Pinson A, Konijn AM, Hershko C. Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med. 1998;131(5):466\u201374.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"619_CR79","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0022-2143(99)90011-2","volume":"133","author":"G Link","year":"1999","unstructured":"Link G, Konijn AM, Hershko C. Cardioprotective effect of \u03b1-tocopherol, ascorbate, deferoxamine, and deferiprone: MItochondrial function in cultured, iron-loaded heart cells. J Lab Clin Med. 1999;133(2):179\u201388.","journal-title":"J Lab Clin Med"},{"key":"619_CR80","doi-asserted-by":"publisher","first-page":"2340392","DOI":"10.1155\/2019\/2340392","volume":"2019","author":"H He","year":"2019","unstructured":"He H, Qiao Y, Zhou Q, Wang Z, Chen X, Liu D, et al. Iron overload damages the endothelial mitochondria via the ROS\/ADMA\/DDAHII\/eNOS\/NO pathway. Oxid Med Cell Longev. 2019;2019:2340392.","journal-title":"Oxid Med Cell Longev"},{"issue":"23","key":"619_CR81","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1161\/01.CIR.103.23.2799","volume":"103","author":"SJ Duffy","year":"2001","unstructured":"Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103(23):2799\u2013804.","journal-title":"Circulation"},{"key":"619_CR82","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.taap.2017.11.005","volume":"338","author":"S Chan","year":"2018","unstructured":"Chan S, Lian Q, Chen M-P, Jiang D, Ho JTK, Cheung Y-F, et al. Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis. Toxicol Appl Pharmacol. 2018;338:148\u201358.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"619_CR83","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2011.01.009","volume":"215","author":"Y Ikeda","year":"2011","unstructured":"Ikeda Y, Tajima S, Yoshida S, Yamano N, Kihira Y, Ishizawa K, et al. Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function. Atherosclerosis. 2011;215(2):339\u201347.","journal-title":"Atherosclerosis"},{"issue":"18","key":"619_CR84","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","volume":"61","author":"A Khechaduri","year":"2013","unstructured":"Khechaduri A, Bayeva M, Chang H-C, Ardehali H. Heme levels are increased in human failing hearts. J Am Coll Cardiol. 2013;61(18):1884\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"619_CR85","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002272","volume":"4","author":"KT Sawicki","year":"2015","unstructured":"Sawicki KT, Shang M, Wu R, Chang HC, Khechaduri A, Sato T, et al. Increased heme levels in the heart lead to exacerbated ischemic injury. J Am Heart Assoc. 2015;4(8): e002272.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"619_CR86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.15252\/emmm.201505748","volume":"8","author":"HC Chang","year":"2016","unstructured":"Chang HC, Wu R, Shang M, Sato T, Chen C, Shapiro JS, et al. Reduction in mitochondrial iron alleviates cardiac damage during injury. EMBO Mol Med. 2016;8(3):247\u201367.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"619_CR87","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/ATVBAHA.120.315393","volume":"41","author":"LL Dunn","year":"2021","unstructured":"Dunn LL, Kong SMY, Tumanov S, Chen W, Cantley J, Ayer A, et al. Hmox1 (Heme Oxygenase-1) protects against ischemia-mediated injury via stabilization of HIF-1\u03b1 (Hypoxia-Inducible Factor-1\u03b1). Arterioscler Thromb Vasc Biol. 2021;41(1):317\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"619_CR88","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.vph.2018.08.011","volume":"112","author":"M Tomczyk","year":"2019","unstructured":"Tomczyk M, Kraszewska I, Dulak J, Jazwa-Kusior A. Modulation of the monocyte\/macrophage system in heart failure by targeting heme oxygenase-1. Vascul Pharmacol. 2019;112:79\u201390.","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"619_CR89","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10020-021-00363-7","volume":"27","author":"X Chen","year":"2021","unstructured":"Chen X, Wan W, Guo Y, Ye T, Fo Y, Sun Y, et al. Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2\/HO-1 signaling pathway. Mol Med. 2021;27(1):100.","journal-title":"Mol Med"},{"issue":"8","key":"619_CR90","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jacbts.2022.03.012","volume":"7","author":"HD Miyamoto","year":"2022","unstructured":"Miyamoto HD, Ikeda M, Ide T, Tadokoro T, Furusawa S, Abe K, et al. Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury. JACC Basic Transl Sci. 2022;7(8):800\u201319.","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"619_CR91","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1101\/gad.1177604","volume":"18","author":"DP Kelly","year":"2004","unstructured":"Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004;18(4):357\u201368.","journal-title":"Genes Dev"},{"issue":"10 Suppl","key":"619_CR92","doi-asserted-by":"publisher","first-page":"E-702-E","DOI":"10.1016\/S0735-1097(13)60702-0","volume":"61","author":"RC Gupta","year":"2013","unstructured":"Gupta RC, Szekely K, Wang M, Zhang K, Rastogi S, Albrecht-K\u00fcpper B, et al. Long-term therapy with the partial adenosine A1-receptor agonist capadenoson, improves peroxisome proliferator-activated receptor coactivator-1\u03b1 phosphorylation and protein expression in left ventricular myocardium of dogs with chronic heart failure. J Am Coll Cardiol. 2013;61(10 Suppl):E-702-E.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"619_CR93","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1182\/blood-2007-07-102335","volume":"111","author":"YS Sohn","year":"2008","unstructured":"Sohn YS, Breuer W, Munnich A, Cabantchik ZI. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood. 2008;111(3):1690\u20139.","journal-title":"Blood"},{"issue":"3","key":"619_CR94","first-page":"1690","volume":"111","author":"Y-S Sohn","year":"2008","unstructured":"Sohn Y-S, Breuer W, Munnich A, Cabantchik ZI. Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood J Am Soc Hematol. 2008;111(3):1690\u20139.","journal-title":"Blood J Am Soc Hematol"},{"issue":"4","key":"619_CR95","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bbrc.2017.03.127","volume":"486","author":"C Zou","year":"2017","unstructured":"Zou C, Liu X, Xie R, Bao Y, Jin Q, Jia X, et al. Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. Biochem Biophys Res Commun. 2017;486(4):930\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"619_CR96","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2377-8-20","volume":"8","author":"S Goncalves","year":"2008","unstructured":"Goncalves S, Paupe V, Dassa EP, Rustin P. Deferiprone targets aconitase: Implication for Friedreich\u2019s ataxia treatment. BMC Neurol. 2008;8(1):20.","journal-title":"BMC Neurol"},{"issue":"4","key":"619_CR97","doi-asserted-by":"publisher","first-page":"C1383","DOI":"10.1152\/ajpcell.00054.2007","volume":"293","author":"M Shvartsman","year":"2007","unstructured":"Shvartsman M, Kikkeri R, Shanzer A, Cabantchik ZI. Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications. Am J Physiol Cell Physiol. 2007;293(4):C1383\u201394.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"619_CR98","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1096\/fj.13-240564","volume":"28","author":"NA Wolff","year":"2014","unstructured":"Wolff NA, Ghio AJ, Garrick LM, Garrick MD, Zhao L, Fenton RA, et al. Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1). FASEB J. 2014;28(5):2134\u201345.","journal-title":"FASEB J"},{"issue":"5","key":"619_CR99","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.bbamcr.2015.01.021","volume":"1853","author":"DJ Lane","year":"2015","unstructured":"Lane DJ, Merlot AM, Huang ML, Bae DH, Jansson PJ, Sahni S, et al. Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease. Biochem Biophys Acta. 2015;1853(5):1130\u201344.","journal-title":"Biochem Biophys Acta"},{"issue":"4","key":"619_CR100","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/MCB.01685-08","volume":"29","author":"PN Paradkar","year":"2009","unstructured":"Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, Kaplan J. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol. 2009;29(4):1007\u201316.","journal-title":"Mol Cell Biol"},{"issue":"38","key":"619_CR101","doi-asserted-by":"publisher","first-page":"16263","DOI":"10.1073\/pnas.0904519106","volume":"106","author":"W Chen","year":"2009","unstructured":"Chen W, Paradkar PN, Li L, Pierce EL, Langer NB, Takahashi-Makise N, et al. Abcb10 physically interacts with mitoferrin-1 (Slc25a37) to enhance its stability and function in the erythroid mitochondria. Proc Natl Acad Sci USA. 2009;106(38):16263\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"619_CR102","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1182\/blood-2002-04-1212","volume":"101","author":"S Taketani","year":"2003","unstructured":"Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T. Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood. 2003;101(8):3274\u201380.","journal-title":"Blood"},{"issue":"11","key":"619_CR103","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1073\/pnas.1119338109","volume":"109","author":"Y Ichikawa","year":"2012","unstructured":"Ichikawa Y, Bayeva M, Ghanefar M, Potini V, Sun L, Mutharasan RK, et al. Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export. Proc Natl Acad Sci USA. 2012;109(11):4152\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"619_CR104","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Investig. 2014;124(2):617\u201330.","journal-title":"J Clin Investig"},{"key":"619_CR105","doi-asserted-by":"crossref","unstructured":"Chang HC, Wu R, Shang M, Sato T, Chen C, Shapiro J, et al. Reduction in mitochondrial iron alleviates cardiac damage during injury. EMBO Mol Med. 2016;8.","DOI":"10.15252\/emmm.201505748"},{"issue":"2","key":"619_CR106","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nm.4021","volume":"22","author":"SM Cloonan","year":"2016","unstructured":"Cloonan SM, Glass K, Laucho-Contreras ME, Bhashyam AR, Cervo M, Pab\u00f3n MA, et al. Mitochondrial iron chelation ameliorates cigarette smoke\u2013induced bronchitis and emphysema in mice. Nat Med. 2016;22(2):163\u201374.","journal-title":"Nat Med"},{"issue":"2","key":"619_CR107","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/cvr\/cvt032","volume":"98","author":"M Kohlhaas","year":"2013","unstructured":"Kohlhaas M, Maack C. Calcium release microdomains and mitochondria. Cardiovasc Res. 2013;98(2):259\u201368.","journal-title":"Cardiovasc Res"},{"key":"619_CR108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2021.06.005","volume":"159","author":"A Paterek","year":"2021","unstructured":"Paterek A, Okni\u0144ska M, Chajduk E, Polkowska-Motrenko H, M\u0105czewski M, Mackiewicz U. Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure. J Mol Cell Cardiol. 2021;159:16\u201327.","journal-title":"J Mol Cell Cardiol"},{"key":"619_CR109","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1038\/srep18132","volume":"5","author":"SK Das","year":"2015","unstructured":"Das SK, Wang W, Zhabyeyev P, Basu R, McLean B, Fan D, et al. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Sci Rep. 2015;5:18132.","journal-title":"Sci Rep"},{"key":"619_CR110","doi-asserted-by":"crossref","unstructured":"Chung YJ, Luo A, Park KC, Loonat AA, Lakhal-Littleton S, Robbins PA, et al. Iron-deficiency anemia reduces cardiac contraction by downregulating RyR2 channels and suppressing SERCA pump activity. JCI Insight. 2019;4(7). https:\/\/insight.jci.org\/articles\/view\/125618","DOI":"10.1172\/jci.insight.125618"},{"issue":"5","key":"619_CR111","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.18632\/aging.101247","volume":"9","author":"DE Crombie","year":"2017","unstructured":"Crombie DE, Curl CL, Raaijmakers AJ, Sivakumaran P, Kulkarni T, Wong RC, et al. Friedreich\u2019s ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency. Aging. 2017;9(5):1440\u201352.","journal-title":"Aging"},{"key":"619_CR112","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/164_2016_123","volume":"243","author":"A von Hardenberg","year":"2017","unstructured":"von Hardenberg A, Maack C. Mitochondrial Therapies in Heart Failure. Handb Exp Pharmacol. 2017;243:491\u2013514.","journal-title":"Handb Exp Pharmacol"},{"key":"619_CR113","doi-asserted-by":"crossref","unstructured":"Chen Y, Li X, Wang S, Miao R, Zhong J. Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases. Nutrients. 2023;15(3). https:\/\/www.mdpi.com\/2072-6643\/15\/3\/591","DOI":"10.3390\/nu15030591"},{"issue":"2","key":"619_CR114","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s11033-022-08048-y","volume":"50","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zhao J, Zhao Y, Zhou L, Qiao H, Xu Q, et al. The role of ferroptosis in neurodegenerative diseases. Mol Biol Rep. 2023;50(2):1655\u201361.","journal-title":"Mol Biol Rep"},{"key":"619_CR115","doi-asserted-by":"publisher","unstructured":"Chen X, Comish PB, Tang D, Kang R. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol. 2021;9:637162. https:\/\/doi.org\/10.3389\/fcell.2021.637162, https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.637162\/full","DOI":"10.3389\/fcell.2021.637162"},{"issue":"4","key":"619_CR116","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"619_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2013.10.002","volume":"53","author":"CIF Janssen","year":"2014","unstructured":"Janssen CIF, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res. 2014;53:1\u201317.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"619_CR118","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez D, Ruiz-Andres O, Poveda J, Carrasco S, Cannata-Ortiz P, Sanchez-Ni\u00f1o MD, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid\u2013induced AKI. J Am Soc Nephrol. 2017;28(1):218\u201329.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"619_CR119","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler A, Schneider M, F\u00f6rster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8(3):237\u201348.","journal-title":"Cell Metab"},{"key":"619_CR120","doi-asserted-by":"crossref","unstructured":"Sun L, Wang H, Yu S, Zhang L, Jiang J, Zhou Q. Herceptin induces ferroptosis and mitochondrial dysfunction in H9c2\u00a0cells. Int J Mol Med. 2022;49(2). https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2021.5072\/abstract","DOI":"10.3892\/ijmm.2021.5072"},{"issue":"5","key":"619_CR121","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38(5):489\u201398.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"619_CR122","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"619_CR123","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","volume":"12","author":"A Rayatpour","year":"2022","unstructured":"Rayatpour A, Foolad F, Heibatollahi M, Khajeh K, Javan M. Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Sci Rep. 2022;12(1):19630.","journal-title":"Sci Rep"},{"key":"619_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-S\u00e1nchez","year":"2021","unstructured":"Mahoney-S\u00e1nchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC. Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease. Prog Neurobiol. 2021;196: 101890.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"619_CR125","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/17474086.2017.1318052","volume":"10","author":"A Belmont","year":"2017","unstructured":"Belmont A, Kwiatkowski JL. Deferiprone for the treatment of transfusional iron overload in thalassemia. Expert Rev Hematol. 2017;10(6):493\u2013503.","journal-title":"Expert Rev Hematol"},{"key":"619_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.02.018","volume":"200","author":"M Lupu","year":"2023","unstructured":"Lupu M, Coada CA, Tudor D-V, Baldea I, Florea A, Toma V-A, et al. Iron chelation alleviates multiple pathophysiological pathways in a rat model of cardiac pressure overload. Free Radical Biol Med. 2023;200:1\u201310.","journal-title":"Free Radical Biol Med"},{"issue":"7","key":"619_CR127","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci. 2019;116(7):2672\u201380.","journal-title":"Proc Natl Acad Sci"},{"key":"619_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28: 101328.","journal-title":"Redox Biol"},{"key":"619_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","volume":"90","author":"R Ni","year":"2016","unstructured":"Ni R, Cao T, Xiong S, Ma J, Fan G-C, Lacefield JC, et al. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radical Biol Med. 2016;90:12\u201323.","journal-title":"Free Radical Biol Med"},{"issue":"9","key":"619_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072858","volume":"8","author":"I Gouni-Berthold","year":"2013","unstructured":"Gouni-Berthold I, Berthold HK, Huh JY, Berman R, Spenrath N, Krone W, et al. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo. PLoS ONE. 2013;8(9): e72858.","journal-title":"PLoS ONE"},{"issue":"5","key":"619_CR131","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/JIM.0000000000000202","volume":"63","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Kebbati AH, Zhang Y, Tang Y, Okello E, Huang C. Effect of coenzyme Q10 on the incidence of atrial fibrillation in patients with heart failure. J Investig Med. 2015;63(5):735\u20139.","journal-title":"J Investig Med"},{"issue":"6","key":"619_CR132","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","volume":"2","author":"SA Mortensen","year":"2014","unstructured":"Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart failure. 2014;2(6):641\u20139.","journal-title":"JACC Heart failure."},{"key":"619_CR133","doi-asserted-by":"crossref","unstructured":"Di Lorenzo A, Iannuzzo G, Parlato A, Cuomo G, Testa C, Coppola M, et al. Clinical evidence for Q10 coenzyme supplementation in heart failure: from energetics to functional improvement. J Clin Med. 2020;9(5):1266. https:\/\/bibliotecadigital.uchile.cl\/discovery\/fulldisplay\/cdi_doaj_primary_oai_doaj_org_article_09047766e74f45abafac5b7153864408\/56UDC_INST:56UDC_INST","DOI":"10.3390\/jcm9051266"},{"issue":"3","key":"619_CR134","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mehy.2009.03.027","volume":"73","author":"E Okello","year":"2009","unstructured":"Okello E, Jiang X, Mohamed S, Zhao Q, Wang T. Combined statin\/coenzyme Q10 as adjunctive treatment of chronic heart failure. Med Hypotheses. 2009;73(3):306\u20138.","journal-title":"Med Hypotheses"},{"issue":"1","key":"619_CR135","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","volume":"497","author":"B Liu","year":"2018","unstructured":"Liu B, Zhao C, Li H, Chen X, Ding Y, Xu S. Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis. Biochem Biophys Res Commun. 2018;497(1):233\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7784","key":"619_CR136","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138.","journal-title":"Nature"},{"issue":"4","key":"619_CR137","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.bbrc.2020.01.066","volume":"523","author":"E Dai","year":"2020","unstructured":"Dai E, Zhang W, Cong D, Kang R, Wang J, Tang D. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523(4):966\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"619_CR138","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","volume":"9","author":"X Sui","year":"2018","unstructured":"Sui X, Zhang R, Liu S, Duan T, Zhai L, Zhang M, et al. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer. Front Pharmacol. 2018;9:1371.","journal-title":"Front Pharmacol"},{"issue":"2","key":"619_CR139","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2019.11.110","volume":"522","author":"E Dai","year":"2020","unstructured":"Dai E, Meng L, Kang R, Wang X, Tang D. ESCRT-III\u2013dependent membrane repair blocks ferroptosis. Biochem Biophys Res Commun. 2020;522(2):415\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"619_CR140","doi-asserted-by":"crossref","unstructured":"Xie LH, Fefelova N, Pamarthi SH, Gwathmey JK. Molecular mechanisms of ferroptosis and relevance to cardiovascular disease. Cells. 2022;11(17):2726. https:\/\/www.mdpi.com\/2073-4409\/11\/17\/2726","DOI":"10.3390\/cells11172726"},{"issue":"2","key":"619_CR141","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225\u201334.","journal-title":"Nat Cell Biol"},{"key":"619_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108241","volume":"680","author":"N Sumneang","year":"2020","unstructured":"Sumneang N, Siri-Angkul N, Kumfu S, Chattipakorn SC, Chattipakorn N. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes. Arch Biochem Biophys. 2020;680: 108241.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"619_CR143","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","volume":"51","author":"WH Tang","year":"2008","unstructured":"Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51(5):569\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"619_CR144","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cardfail.2021.03.010","volume":"27","author":"P Martens","year":"2021","unstructured":"Martens P, Claessen G, Van De Bruaene A, Verbrugge FH, Herbots L, Dendale P, et al. Iron deficiency is associated with impaired biventricular reserve and reduced exercise capacity in patients with unexplained dyspnea. J Cardiac Fail. 2021;27(7):766\u201376.","journal-title":"J Cardiac Fail"},{"issue":"19","key":"619_CR145","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017;317(19):1958\u201366.","journal-title":"JAMA"},{"issue":"25","key":"619_CR146","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436\u201348.","journal-title":"N Engl J Med"},{"issue":"11","key":"619_CR147","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J. 2014;36(11):657\u201368.","journal-title":"Eur Heart J"},{"issue":"10266","key":"619_CR148","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski P, Kirwan B-A, Anker SD, McDonagh T, Dorobantu M, Drozdz J, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. The Lancet. 2020;396(10266):1895\u2013904.","journal-title":"The Lancet"},{"issue":"1","key":"619_CR149","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ehf2.13753","volume":"9","author":"R L\u00f3pez-Vilella","year":"2022","unstructured":"L\u00f3pez-Vilella R, Lozano-Edo S, Arenas Mart\u00edn P, Jover-Pastor P, Ezzitouny M, Sorolla Romero J, et al. Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction. ESC Heart Fail. 2022;9(1):133\u201345.","journal-title":"ESC Heart Fail."},{"key":"619_CR150","doi-asserted-by":"crossref","unstructured":"Mollace A, Macr\u00ec R, Mollace R, Tavernese A, Gliozzi M, Musolino V, et al. Effect of ferric carboxymaltose supplementation in patients with heart failure with preserved ejection fraction: role of attenuated oxidative stress and improved endothelial function. Nutrients. 2022;14(23):5057. https:\/\/www.mdpi.com\/2072-6643\/14\/23\/5057","DOI":"10.3390\/nu14235057"},{"issue":"6","key":"619_CR151","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1002\/ehf2.13053","volume":"7","author":"E Santas","year":"2020","unstructured":"Santas E, Mi\u00f1ana G, Cardells I, Palau P, Ll\u00e0cer P, F\u00e1cila L, et al. Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial. ESC Heart Fail. 2020;7(6):4222\u201330.","journal-title":"ESC Heart Fail."},{"issue":"1","key":"619_CR152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1540-8175.2011.01532.x","volume":"29","author":"R Gaber","year":"2012","unstructured":"Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A. Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography (Mount Kisco, NY). 2012;29(1):13\u20138.","journal-title":"Echocardiography (Mount Kisco, NY)."},{"key":"619_CR153","doi-asserted-by":"crossref","unstructured":"Salah HM, Savarese G, Rosano GMC, Ambrosy AP, Mentz RJ, Fudim M. Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis. ESC Heart Fail. 2023.","DOI":"10.1002\/ehf2.14310"},{"issue":"7","key":"619_CR154","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ejhf.467","volume":"18","author":"M Stugiewicz","year":"2016","unstructured":"Stugiewicz M, Tkaczyszyn M, Kasztura M, Banasiak W, Ponikowski P, Jankowska EA. The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications. Eur J Heart Fail. 2016;18(7):762\u201373.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"619_CR155","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/ejhf.2628","volume":"24","author":"S Caravita","year":"2022","unstructured":"Caravita S, Faini A, Vignati C, Pelucchi S, Salvioni E, Cattadori G, et al. Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure. Eur J Heart Fail. 2022;24(10):1940\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"619_CR156","doi-asserted-by":"publisher","first-page":"391","DOI":"10.5603\/CJ.a2020.0138","volume":"28","author":"M Tkaczyszyn","year":"2021","unstructured":"Tkaczyszyn M, Drozd M, W\u0119grzynowska-Teodorczyk K, Bojarczuk J, Majda J, Banasiak W, et al. Iron status, catabolic\/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction. Cardiol J. 2021;28(3):391\u2013401.","journal-title":"Cardiol J"},{"issue":"11","key":"619_CR157","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, Butler J, De Pasquale CG, Ezekowitz JA, et al. Ferric carboxymaltose in heart failure with iron deficiency. N Engl J Med. 2023;389(11):975\u201386.","journal-title":"N Engl J Med"},{"issue":"10369","key":"619_CR158","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2023","unstructured":"Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, et al. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet (London, England). 2023;400(10369):2199\u2013209.","journal-title":"Lancet (London, England)."},{"issue":"48","key":"619_CR159","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1093\/eurheartj\/ehab411","volume":"42","author":"P Martens","year":"2021","unstructured":"Martens P, Dupont M, Dauw J, Nijst P, Herbots L, Dendale P, et al. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial. Eur Heart J. 2021;42(48):4905\u201314.","journal-title":"Eur Heart J"},{"issue":"6","key":"619_CR160","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ejhf.2489","volume":"24","author":"P Martens","year":"2022","unstructured":"Martens P, Dupont M, Dauw J, Nijst P, Bertrand PB, Tang WHW, et al. The effect of intravenous ferric carboxymaltose on right ventricular function\u2014insights from the IRON-CRT trial. Eur J Heart Fail. 2022;24(6):1106\u201313.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"619_CR161","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.hlc.2014.12.161","volume":"24","author":"JE Toblli","year":"2015","unstructured":"Toblli JE, Di Gennaro F, Rivas C. Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron. Heart Lung Circ. 2015;24(7):686\u201395.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"619_CR162","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mrfmmm.2003.08.004","volume":"531","author":"M Kruszewski","year":"2003","unstructured":"Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res\/Fund Mol Mech Mutagen. 2003;531(1):81\u201392.","journal-title":"Mutat Res\/Fund Mol Mech Mutagen"},{"issue":"11","key":"619_CR163","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33935","volume":"4","author":"AA Shah","year":"2021","unstructured":"Shah AA, Donovan K, Seeley C, Dickson EA, Palmer AJR, Doree C, et al. Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(11): e2133935-e.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"619_CR164","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ajh.25060","volume":"93","author":"NF Adkinson","year":"2018","unstructured":"Adkinson NF, Strauss WE, Macdougall IC, Bernard KE, Auerbach M, Kaper RF, et al. Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial. Am J Hematol. 2018;93(5):683\u201390.","journal-title":"Am J Hematol"},{"key":"619_CR165","doi-asserted-by":"crossref","unstructured":"Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W. Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight. 2018;3(23).","DOI":"10.1172\/jci.insight.124486"},{"issue":"11","key":"619_CR166","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.3324\/haematol.2020.250803","volume":"106","author":"MW Garbowski","year":"2021","unstructured":"Garbowski MW, Bansal S, Porter JB, Mori C, Burckhardt S, Hider RC. Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways. Haematologica. 2021;106(11):2885. https:\/\/www.haematologica.org\/article\/view\/haematol.2020.250803","journal-title":"Haematologica"},{"issue":"5","key":"619_CR167","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2019.22450","volume":"323","author":"M Wolf","year":"2020","unstructured":"Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, et al. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials. JAMA. 2020;323(5):432\u201343.","journal-title":"JAMA"},{"issue":"1","key":"619_CR168","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3324\/haematol.2009.019042","volume":"96","author":"A Pepe","year":"2011","unstructured":"Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, et al. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. Haematologica. 2011;96(1):41\u20137.","journal-title":"Haematologica"},{"issue":"14","key":"619_CR169","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","volume":"115","author":"MA Tanner","year":"2007","unstructured":"Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007;115(14):1876\u201384.","journal-title":"Circulation"},{"key":"619_CR170","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jnc.12300","volume":"126","author":"M Pandolfo","year":"2013","unstructured":"Pandolfo M, Hausmann L. Deferiprone for the treatment of Friedreich\u2019s ataxia. J Neurochem. 2013;126:142\u20136.","journal-title":"J Neurochem"},{"issue":"7","key":"619_CR171","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3324\/haematol.2016.162917","volume":"102","author":"K Mleczko-Sanecka","year":"2017","unstructured":"Mleczko-Sanecka K, da Silva AR, Call D, Neves J, Schmeer N, Damm G, et al. Imatinib and spironolactone suppress hepcidin expression. Haematologica. 2017;102(7):1173\u201384.","journal-title":"Haematologica"},{"issue":"1","key":"619_CR172","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yjmcc.2008.09.714","volume":"46","author":"S Omiya","year":"2009","unstructured":"Omiya S, Hikoso S, Imanishi Y, Saito A, Yamaguchi O, Takeda T, et al. Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes. J Mol Cell Cardiol. 2009;46(1):59\u201366.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"619_CR173","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","volume":"25","author":"FJ Graham","year":"2023","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JGF. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. Eur J Heart Fail. 2023;25(4):528\u201337.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"619_CR174","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"G Masini","year":"2022","unstructured":"Masini G, Graham FJ, Pellicori P, Cleland JGF, Cuthbert JJ, Kazmi S, et al. Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol. 2022;79(4):341\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"619_CR175","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.amjcard.2013.11.061","volume":"113","author":"M Nagao","year":"2014","unstructured":"Nagao M, Matsuo Y, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, et al. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging. Am J Cardiol. 2014;113(6):1024\u201330.","journal-title":"Am J Cardiol"},{"issue":"14","key":"619_CR176","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","volume":"123","author":"J-P Carpenter","year":"2011","unstructured":"Carpenter J-P, He T, Kirk P, Roughton M, Anderson LJ, Noronha SVd, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519\u201328.","journal-title":"Circulation"},{"issue":"3","key":"619_CR177","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacbts.2019.08.009","volume":"5","author":"K Ghafourian","year":"2020","unstructured":"Ghafourian K, Shapiro JS, Goodman L, Ardehali H. Iron and Heart Failure. JACC Basic Transl Sci. 2020;5(3):300\u201313.","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"619_CR178","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00395-020-0782-6","volume":"115","author":"B Behrouzi","year":"2020","unstructured":"Behrouzi B, Weyers JJ, Qi X, Barry J, Rabadia V, Manca D, et al. Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction. Basic Res Cardiol. 2020;115(3):24.","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"619_CR179","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/cvr\/cvad092","volume":"119","author":"B Chung","year":"2023","unstructured":"Chung B, Wang Y, Thiel M, Rostami F, Rogoll A, Hirsch VG, et al. Pre-emptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction. Cardiovasc Res. 2023;119(10):1969\u201380.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"619_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44460","volume":"7","author":"S Wongjaikam","year":"2017","unstructured":"Wongjaikam S, Kumfu S, Khamseekaew J, Chattipakorn SC, Chattipakorn N. Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine. Sci Rep. 2017;7(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"7","key":"619_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159414","volume":"11","author":"S Wongjaikam","year":"2016","unstructured":"Wongjaikam S, Kumfu S, Khamseekaew J, Sripetchwandee J, Srichairatanakool S, Fucharoen S, et al. Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats. PLoS ONE. 2016;11(7): e0159414.","journal-title":"PLoS ONE"},{"issue":"1","key":"619_CR182","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13578-021-00605-5","volume":"11","author":"M Tajes","year":"2021","unstructured":"Tajes M, D\u00edez-L\u00f3pez C, Enjuanes C, Moliner P, Ferreiro JL, Garay A, et al. Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells. Cell Biosci. 2021;11(1):89.","journal-title":"Cell Biosci"},{"issue":"21","key":"619_CR183","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.3390\/jcm10214937","volume":"10","author":"C D\u00edez-L\u00f3pez","year":"2021","unstructured":"D\u00edez-L\u00f3pez C, Tajes Ordu\u00f1a M, Enjuanes Grau C, Moliner Borja P, Gonz\u00e1lez-Costello J, Garc\u00eda-Romero E, et al. Blood differential gene expression in patients with chronic heart failure and systemic iron deficiency: pathways involved in pathophysiology and impact on clinical outcomes. J Clin Med. 2021;10(21):4937.","journal-title":"J Clin Med"},{"issue":"11","key":"619_CR184","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022853","volume":"11","author":"H Zhang","year":"2022","unstructured":"Zhang H, Jamieson KL, Grenier J, Nikhanj A, Tang Z, Wang F, et al. Myocardial iron deficiency and mitochondrial dysfunction in advanced heart failure in humans. J Am Heart Assoc. 2022;11(11): e022853.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"619_CR185","doi-asserted-by":"publisher","first-page":"442","DOI":"10.52586\/4958","volume":"26","author":"S Bhandari","year":"2021","unstructured":"Bhandari S. Impact of intravenous iron on cardiac and skeletal oxidative stress and cardiac mitochondrial function in experimental uraemia chronic kidney disease. Front Biosci (Landmark edition). 2021;26(9):442\u201364.","journal-title":"Front Biosci (Landmark edition)."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-023-00619-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-023-00619-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-023-00619-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T01:35:50Z","timestamp":1730943350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-023-00619-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":185,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s40256-023-00619-z","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"20 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Seyed Ali Mousavi-Aghdas, Nasim Naderi and Ebrahim Farashi declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated in the preparation of this manuscript.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Seyed Ali Mousavi-Aghdas: Conceptualization, data curation, investigation, methodology, visualization, writing, reviewing and editing. Ebrahim Farashi: Data curation, writing Nasim Naderi: Conceptualization, investigation, project administration, supervision, reviewing and editing.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contribution"}}]}}